ClinicalTrials.gg
RecruitingNCT07746531MAGENTAUpdated Nov 17, 2026

Robotic Minimally Invasive Benign Hysterectomy Post-Market Clinical Study With the DEXTER Robotic System

An observational study in Hysterectomy, Benign Uterine Diseases, sponsored by Distalmotion SA. Recruiting at 2 sites in United States. Open to female participants aged 22 Years and older. Per ClinicalTrials.gov, last updated 2026-11-17.

Sponsored by Distalmotion SA · Observational

How we know

From the registry’s dates

  • Started Aug 2026; still recruiting 3 months later.
Updated Nov 17, 2026Now RecruitingSite recruiting status changed+1 moreGo to Updates ↓

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Study type
Observational
Model
Case-only
Time perspective
Prospective
Enrollment
112
Ages
22 Years and older
Sex
Female
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 17 studies in Uterine Diseases with a site in United States — 3 open to participants now, 4 under way, none of them phase 3. Uterine Diseases · United States.

Started
2026
the only one that year
Observational
2 of 17
1 open now
Registered
17th of 17
by date
Lead sponsor
1 of 17
Distalmotion SA

Among the 17 studies in Uterine Diseases with a site in United States, this one is the only one that started in 2026, is one of 2 observational ones, and was the 17th registered.

Uterine Diseases

73 studies on the registry are indexed under Uterine Diseases; 9 are open to participants now.

Browse Uterine Diseases studies →

Open to participants now

3 of the 17 studies in Uterine Diseases with a site in United States are open now. Recruiting first, the newest first:

All 3 open studies →

A study can be open while its sites in United States have not opened yet or have stopped. Only those recruiting at a site in United States →

Who these studies take

Of the 8 Uterine Diseases studies recruiting now, 3 set no upper age limit and 5 stop at 75 or younger; none take children under 18; 1 takes healthy volunteers.

This study: 22 Years and older · female · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 17 studies in Uterine Diseases with a site in United States, or all of them as a file.
02

Study summary

The purpose of this post-market, observational study is to collect real-world data under anticipated conditions of use that demonstrates that the device performs as intended (accurate, precise control of surgical instruments) in patients undergoing robotic-assisted and laparoscopic hysterectomy for benign disease.

03

Conditions studied

  • Hysterectomy, Benign Uterine Diseases

Browse trials for

04

Who can participate

Ages eligible
22 Years and older
Sexes eligible
Female
Accepts healthy volunteers
No
Sampling method
Non-probability sample

Study population

Adult patients undergoing a hysterectomy for benign disease

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Patient is ≥ 22 years of age at time of enrollment/consent
  • Patient is planned to undergo robotic-assisted and laparoscopic hysterectomy for benign disease
  • Patient agrees to perform the 6-week follow-up assessment as per standard of care

Exclusion criteria

Exclusion Criteria:

  • Any planned concomitant procedures (not including salpingectomy and/or oophorectomy)
  • Diagnosed malignant disease on reproductive organs
  • Uterus myomatous with fibroid > 10cm
05

Study design

Observational model
Case-only
Time perspective
Prospective
Enrollment
112 participants (estimated)
Patient registry
No

Interventions

  • Devicebenign hysterectomy

    Robotic-assisted and laparoscopic hysterectomy for benign disease with the DEXTER robotic surgery system.

06

What researchers measure

Primary outcomes

  1. Primary safety outcome

    Occurrence of Clavien-Dindo grades III-V adverse events

    Time frame: up to 42 days after surgery

  2. Primary efficacy outcome

    Successful completion of the DEXTER-assisted procedure, i.e. free of any conversion to an open or fully laparoscopic surgical approach

    Time frame: Intraoperative

07

Study locations

1 of 2 sites recruiting
  • Cypress surgery center
    Wichita, Kansas 67226, United States
    Recruiting
  • Memorial Hermann-Texas Medical Center - UT Health Houston
    Houston, Texas 77030-1501, United States
    Not yet recruiting
08

Timeline

1 registry update since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reached

Started Aug 2026 (actual). Primary completion is estimated for Dec 2028, 28 months after the start.

How these figures are worked out, and which studies are left out of them.

Registered
Jul 31, 2026
First posted
Aug 5, 2026
StartActual
Aug 20, 2026
Primary completionEst.
Dec 2028
CompletionEst.
Dec 2028
Last update
Nov 17, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
Status
Not yet recruiting→Recruiting
changed Nov 17, 2026
Sites
2 sites changed recruiting status (1 now recruiting, 1 now not yet recruiting)
Show 2 sites
  • Cypress surgery center · Wichita, United Statesno status→Recruiting
  • Memorial Hermann-Texas Medical Center - UT Health Houston · Houston, United Statesno status→Not yet recruiting
Nov 17, 2026
Start date
Aug 7, 2026→Aug 20, 2026 (actual)
Nov 17, 2026
Show all 1 update
  1. Nov 17, 2026
    Not yet recruiting→Recruiting
    2 sites changed recruiting status (1 now recruiting, 1 now not yet recruiting)
    Show 2 sites
    • Cypress surgery center · Wichita, United Statesno status→Recruiting
    • Memorial Hermann-Texas Medical Center - UT Health Houston · Houston, United Statesno status→Not yet recruiting
    Start date Aug 7, 2026→Aug 20, 2026 (now actual)
    + 2 other changes: identifiers and verification date

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

09

Registry details

Key details

Study ID
NCT07746531
Lead sponsor
Distalmotion SA
Responsible party
Sponsor
First posted
Aug 5, 2026
Start date
Aug 20, 2026
Primary completion
Dec 2028 (estimated)
Completion
Dec 2028 (estimated)
Last update
Nov 17, 2026

Study contacts

Pascal Lehmann
Contact
pascal.lehmann@distalmotion.com
+41215105890

Oversight

Data monitoring committee
No
FDA-regulated drug
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion